Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation.
Champagne J, Nielsen MM, Feng X, Montenegro Navarro J, Pataskar A, Voogd R, Giebel L, Nagel R, Berenst N, Fumagalli A, Kochavi A, Lovecchio D, Valcanover L, Malka Y, Yang W, Laos M, Li Y, Proost N, van de Ven M, van Tellingen O, Bleijerveld OB, Haanen JBAG, Olweus J, Agami R.
Champagne J, et al. Among authors: giebel l.
Immunity. 2024 Dec 25:S1074-7613(24)00568-5. doi: 10.1016/j.immuni.2024.12.004. Online ahead of print.
Immunity. 2024.
PMID: 39755122